Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects.
Kiuchi
T
T
Department of Transplantation Immunology, Faculty of Medicine, Kyoto University, Japan.
Tanaka
K
K
Inomata
Y
Y
Uemoto
S
S
Satomura
K
K
Egawa
H
H
Uyama
S
S
Sano
K
K
Okajima
H
H
Yamaoka
Y
Y
D000328:Adult; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D004347:Drug Interactions; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007223:Infant; D007538:Isoniazid / Q000627:therapeutic use; D016031:Liver Transplantation / Q000276:immunology*; D019520:Living Donors; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D011183:Postoperative Complications; D012293:Rifampin / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
D000904:Antibiotics, Antitubercular; D007166:Immunosuppressive Agents; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D016559:Tacrolimus; D013307:Streptomycin